UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 386

Sortiert nach

Rapid detection of SARS-CoV-2 antibodies using electrochemical impedance-based detector

Biosensors & bioelectronics, 2021-01, Vol.171, p.112709-112709, Article 112709

2021

Link zum Volltext

Verfügbarkeit prüfen

Plant-derived exosomal microRNAs inhibit lung inflammation induced by exosomes SARS-CoV-2 Nsp12

Molecular therapy, 2021-08, Vol.29 (8), p.2424-2440

2021

Link zum Volltext

Verfügbarkeit prüfen

Design of Poly(lactic- co -glycolic Acid) (PLGA) Nanoparticles for Vaginal Co-Delivery of Griffithsin and Dapivirine and Their Synergistic Effect for HIV Prophylaxis

Pharmaceutics, 2019-04, Vol.11 (4), p.184

2019

Link zum Volltext

Verfügbarkeit prüfen

Activity of and Effect of Subcutaneous Treatment with the Broad-Spectrum Antiviral Lectin Griffithsin in Two Laboratory Rodent Models

Antimicrobial Agents and Chemotherapy, 2014-01, Vol.58 (1), p.120-127

2014

Link zum Volltext

Verfügbarkeit prüfen

Griffithsin Has Antiviral Activity against Hepatitis C Virus

Antimicrobial Agents and Chemotherapy, 2011-11, Vol.55 (11), p.5159-5167

2011

Link zum Volltext

Verfügbarkeit prüfen

Griffithsin Protects Mice from Genital Herpes by Preventing Cell-to-Cell Spread

Journal of Virology, 2013-06, Vol.87 (11), p.6257-6269

2013

Link zum Volltext

Verfügbarkeit prüfen

Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae

Journal of Virology, 2010-03, Vol.84 (5), p.2511-2521

2010

Link zum Volltext

Verfügbarkeit prüfen

A topical rectal douche product containing Q-Griffithsin does not disrupt the epithelial border or alter CD4 + cell distribution in the human rectal mucosa

Scientific reports, 2023-05, Vol.13 (1), p.7547-7547, Article 7547

2023

Link zum Volltext

Verfügbarkeit prüfen

Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component

Proceedings of the National Academy of Sciences - PNAS, 2009-04, Vol.106 (15), p.6099-6104

2009

Link zum Volltext

Verfügbarkeit prüfen

Investigation of griffithsin's interactions with human cells confirms its outstanding safety and efficacy profile as a microbicide candidate

PloS one, 2011-08, Vol.6 (8), p.e22635

2011

Link zum Volltext

Verfügbarkeit prüfen

Studies in a Murine Model Confirm the Safety of Griffithsin and Advocate Its Further Development as a Microbicide Targeting HIV-1 and Other Enveloped Viruses

Viruses, 2016-11, Vol.8 (11), p.311-311

2016

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of the Antiviral Lectin Griffithsin Administered by Different Routes Indicates Multiple Potential Uses

Viruses, 2016-12, Vol.8 (12), p.331-331

2016

Link zum Volltext

Verfügbarkeit prüfen

Serological assessment of SARS-CoV-2 infection during the first wave of the pandemic in Louisville Kentucky

Scientific reports, 2021-09, Vol.11 (1), p.18285-12, Article 18285

2021

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of a product acceptability questionnaire for intranasal Q-Griffithsin COVID-19 prophylaxis (SPRAY PAL)

BMJ open, 2023-09, Vol.13 (9), p.e073735-e073735

2023

Link zum Volltext

Verfügbarkeit prüfen

Antiviral lectin Q-Griffithsin suppresses fungal infection in murine models of vaginal candidiasis

Frontiers in cellular and infection microbiology, 2022-10, Vol.12, p.976033

2022

Link zum Volltext

Verfügbarkeit prüfen

Technoeconomic Modeling of Plant-Based Griffithsin Manufacturing

Frontiers in bioengineering and biotechnology, 2018-07, Vol.6, p.102

2018

Link zum Volltext

Verfügbarkeit prüfen

Novel Antifungal Activity of Q-Griffithsin, a Broad-Spectrum Antiviral Lectin

Microbiology spectrum, 2021-10, Vol.9 (2), p.e0095721

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficient Single Tobamoviral Vector-Based Bioproduction of Broadly Neutralizing Anti-HIV-1 Monoclonal Antibody VRC01 in Nicotiana benthamiana Plants and Utility of VRC01 in Combination Microbicides

Antimicrobial Agents and Chemotherapy, 2013-05, Vol.57 (5), p.2076-2086

2013

Link zum Volltext

Verfügbarkeit prüfen

Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 Vaccination

Vaccines (Basel), 2022-08, Vol.10 (8), p.1363

2022

Link zum Volltext

Verfügbarkeit prüfen

Recombinant protein expression in Nicotiana

Methods in molecular biology (Clifton, N.J.), 2011-01, Vol.701, p.199

2011

Link zum Volltext

Verfügbarkeit prüfen

Dynamic SARS-CoV-2 surveillance model combining seroprevalence and wastewater concentrations for post-vaccine disease burden estimates

Communications medicine, 2024-04, Vol.4 (1), p.70-70, Article 70

2024

Link zum Volltext

Verfügbarkeit prüfen

Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2

Science (American Association for the Advancement of Science), 2021-08, Vol.373 (6557), p.931-936

2021

Link zum Volltext

Verfügbarkeit prüfen

Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin

Antiviral research, 2016-09, Vol.133, p.1-8

2016

Link zum Volltext

Verfügbarkeit prüfen

CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated Immunopathology

Vaccines (Basel), 2021-11, Vol.9 (11), p.1346

2021

Link zum Volltext

Verfügbarkeit prüfen

Using SARS-CoV-2 Antibody Testing in COVID-19 Research

The American journal of medicine, 2023-06, Vol.136 (6), p.501-503

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 386

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(362)
Mit Volltextzugriff
(349)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(263)
Life Sciences & Biomedicine
(225)
Humans
(160)
Female
(97)
Biological And Medical Sciences
(84)
Male
(68)
Animals
(62)
Medical Sciences
(61)
Adult
(42)
Fundamental And Applied Biological Sciences. Psychology
(31)
Mice
(30)
Middle Aged
(29)
Pregnancy
(28)
Aged
(26)
Physical Sciences
(25)
Risk Factors
(23)
General & Internal Medicine
(22)
Genetics & Heredity
(21)
Science & Technology - Other Topics
(21)
Virology
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Rapid detection of SARS-CoV-2 antibodies using electrochemical impedance-based detector

Plant-derived exosomal microRNAs inhibit lung inflammation induced by exosomes SARS-CoV-2 Nsp12

Design of Poly(lactic- co -glycolic Acid) (PLGA) Nanoparticles for Vaginal Co-Delivery of Griffithsin and Dapivirine and Their Synergistic Effect for HIV Prophylaxis

Activity of and Effect of Subcutaneous Treatment with the Broad-Spectrum Antiviral Lectin Griffithsin in Two Laboratory Rodent Models

Griffithsin Has Antiviral Activity against Hepatitis C Virus

Griffithsin Protects Mice from Genital Herpes by Preventing Cell-to-Cell Spread

Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae

A topical rectal douche product containing Q-Griffithsin does not disrupt the epithelial border or alter CD4 + cell distribution in the human rectal mucosa

Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component

Investigation of griffithsin's interactions with human cells confirms its outstanding safety and efficacy profile as a microbicide candidate

Studies in a Murine Model Confirm the Safety of Griffithsin and Advocate Its Further Development as a Microbicide Targeting HIV-1 and Other Enveloped Viruses

Pharmacokinetics of the Antiviral Lectin Griffithsin Administered by Different Routes Indicates Multiple Potential Uses

Serological assessment of SARS-CoV-2 infection during the first wave of the pandemic in Louisville Kentucky

Development and validation of a product acceptability questionnaire for intranasal Q-Griffithsin COVID-19 prophylaxis (SPRAY PAL)

Antiviral lectin Q-Griffithsin suppresses fungal infection in murine models of vaginal candidiasis

Technoeconomic Modeling of Plant-Based Griffithsin Manufacturing

Novel Antifungal Activity of Q-Griffithsin, a Broad-Spectrum Antiviral Lectin

Efficient Single Tobamoviral Vector-Based Bioproduction of Broadly Neutralizing Anti-HIV-1 Monoclonal Antibody VRC01 in Nicotiana benthamiana Plants and Utility of VRC01 in Combination Microbicides

Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 Vaccination

Recombinant protein expression in Nicotiana

Dynamic SARS-CoV-2 surveillance model combining seroprevalence and wastewater concentrations for post-vaccine disease burden estimates

Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2

Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin

CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated Immunopathology

Using SARS-CoV-2 Antibody Testing in COVID-19 Research

Suchergebnisse filtern